Global Research Collaborations at PROTON
At PROTON, we pride ourselves on our global collaborative efforts, having partnered with esteemed researchers from over 40 countries to pioneer quality research in the field of ophthalmology. Our dedication to advancing ocular health has led to significant breakthroughs, notably through projects like the Collaborative Ocular Tuberculosis Study (COTS) , OASIS and the Comprehensive Ocular Imaging Network (COIN).
COTS has been a cornerstone in reshaping the diagnosis and study of ocular tuberculosis, providing groundbreaking insights that have influenced global practices. Similarly, COIN has contributed ophthalmology with its advancements in image analysis techniques and software, setting new techniques in ocular imaging.
Today, PROTON is actively engaged with collaborators from approximately 20 countries, and our network continues to grow daily. The contributions from our international partners are invaluable, driving us towards making a lasting impact in the world of ophthalmology.
We are always on the lookout for passionate uveitis specialists who are committed to making a difference. If you have a solid track record of patient documentation, the time and interest to participate in cutting-edge research, we would love to hear from you.
Join us in our mission to innovate and improve OIID on a global scale. For collaboration inquiries, please contact us at: contact@protonstudy.org
Together, let's shape the future of OIID.
Local Collaborators
PROTON is a groundbreaking research initiative spearheaded by the National Health Group at Tan Tock Seng Hospital (NHG), in collaboration with the steady support of (NTU, NUS and Duke-NUS) and A Star, SERI and SUTD and abroad.
The Centre for Microbiome Medicine is dedicated to improve human health by preventing disease, optimising treatments, promoting healthy living and ageing, through innovative ways to monitor and modulate the microbiome.
The Centre for Microbiome Medicine is dedicated to improve human health by preventing disease, optimising treatments, promoting healthy living and ageing, through innovative ways to monitor and modulate the microbiome.
The A*STAR Institute of Molecular and Cell Biology (IMCB) is a premier research institute whose mission is to harness biology for transformational bio-therapeutics and diagnostics. With a strong emphasis on collaboration with stakeholders across the ecosystem in Singapore, IMCB aims to achieve scientific excellence and continues to nurture the next generation of scientists in order to create growth and enhance lives.
Computer vision applications including scene understanding and generative learning.
Aims to develop a strong network of shared platforms that will improve patient care, allow for multicentre trials, and will foster collaborations in several research themes spanning from posterior pole applications towards corneal OCT angiography.
Aims to provide cutting-edge data analytics to the rest of the research themes within LKCMedicine as well as the school's clinical partners and the broader research ecosystem.
It is a state of the art facility that provides flow cytometric services to the Immunology Programme, and also to many other users inside and outside NUS.
It explores unique physical phenomena associated with fluid flows at small length scales and their interactions with structures, electrics, acoustics, optics and magnetics.
Khoo Teck Puat Hospital (KTPH) is a general and acute care hospital located in the northern sector of Singapore. Set within a healing environment, KTPH combines medical expertise with high standards of personalised care to provide care that is good enough for our own loved ones.
Focused in the detection of blood-based biomarkers and neuroimaging tests for the early diagnosis of dementia, paving the way for potential new prevention therapies and treatments for Alzheimer’s disease and other related diseases of the brain.
The team employs a diverse set of methods, including surveys, predictive modeling, data mining, cost analysis, and simulation, to support stakeholders in addressing both specific and systemic health care issues. This includes evaluating individual disease management programs and broader continuity of care initiatives.
Their work that focuses on molecular dynamics simulations and data analysis methods for studying peptides and proteins, specifically their folding and misfolding mechanisms linked to amyloid fibrils. It also covers DNA and RNA dynamics, their interactions with proteins and counterions, and the role of machine learning in drug discovery. Collaborations with experimental groups enhance the understanding of these processes at the molecular and atomic levels.
The Tear Research Network (TRN), launched in May 2022, aims to bring together clinicians, scientists, and researchers around the world that are involved in tear fluid research, education and development. The mission of the Tear Research Network is to lead the way in the use of tear fluid biomarkers in the clinical setting. This aligns with PROTON research because we are validating diagnostic and prognostic biomarkers for uveitis in tears.
